Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Psilocybin for Treatment-Resistant Depression
Brain and Cognition Discovery Foundation
Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy
Celgene
Effectiveness of Ketamine Administered by Mesotherapy in Complex Regional Pain Syndrome Type 1 (CRPS1)
Hospices Civils de Lyon
Stanford Regulating Circuits of the Brain Study - MDMA
Stanford University
Intranasal Ketamine in Ultra-REsistant Depression (SURE-ECT Non Responders)
Centre for Addiction and Mental Health
Synaptic Imaging and Network Activity in Treatment Resistant Depression
King's College London
Characteristics and Treatment Patterns of Patients With Sickle Cell Disease in Globin Research Network for Data and Discovery Registry
Novartis
Benefits of Opioid Free Anesthesia on Morphine Consumption in Gastric Bypass
matthieu clanet
Comparison of Nebulized Ketamine to Intravenous Sub-Dissociative Dose Ketamine for Pain
Antonios Likourezos
A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD)
Remedy
Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer
University of Utah
Low Dose Ketamine for Blunt Thoracic Trauma
North Memorial Health Care
Glutamate and Opioid Mechanisms of Antidepressant Response to Ketamine
King's College London
Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects
Beckley Psytech Limited
Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants
Supernus Pharmaceuticals, Inc.
Entheogen Resurgence
Vireo Health
Repeated Neurocognitive Measurements in Depressed Patients
Rebecca Price
Ketamine As an Adjunctive Therapy for Major Depression (2)
University of Dublin, Trinity College
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
University Hospital, Basel, Switzerland
Pharmacokinetic Study of Intranasal CT001 in Children 1-17 Years of Age Undergoing Elective Surgical Procedures
Cessatech A/S
Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease
Joshua Woolley, MD, PhD
Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness
University Hospital, Basel, Switzerland
Repeat Dosing of Psilocybin in Migraine Headache
Yale University
Opioid Free Anesthesia and Bariatric Surgery
Northwell Health
Drug Effects on Interpersonal Interaction
University of Chicago
MDMA-Assisted Psychotherapy in Veterans With Combat-Related, Refractory PTSD
VA Loma Linda Health Care System
A Proof-of-Concept Trial on the Effect of Ketamine on Fatigue
National Institute of Nursing Research (NINR)
Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS
Novartis Pharmaceuticals
A Study of MELT-300 (Midazolam and Ketamine Sublingual Tablets) for Sedation and Intraoperative Ocular Analgesia in Participants Undergoing Cataract Extraction With Lens Replacement (CELR)
Melt Pharmaceuticals
Pharmacokinetics of GH001 in Healthy Volunteers
GH Research Ireland Limited
The Effect of Opioid-Free Anesthesia in TMJ Surgery
Massachusetts General Hospital
Effects of Dimethyltryptamine in Healthy Subjects
University Hospital, Basel, Switzerland
Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression
Central Institute of Mental Health, Mannheim
Effects of S-ketamine on Perioperative Opioid Consumption
Erasme University Hospital
Adding Trauma-focused Psychotherapy to Ketamine Treatment for Chronic PTSD
Icahn School of Medicine at Mount Sinai
Precision Functional Brain Mapping in Psilocybin
Washington University School of Medicine
Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study
Imperial College London
Pilot RECAP Study in Healthy Volunteers
University of Wisconsin, Madison
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study
University of Colorado, Denver
Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy
University of California, San Diego
Ketamine Versus Fentanyl for Surgical Abortions
University of Washington
Effect of Postoperative Single Dose of Ketamine on Pain After Mastectomy
NYU Langone Health
A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment
Janssen-Cilag Ltd.
A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal Pain
Antonios Likourezos
An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin in Treatment of Acute Headache
Antonios Likourezos
Modified Ketogenic Diet and Ketamine for Anorexia Nervosa
Homeostasis Therapeutics, LLC
The Impact of Perioperative Ketamine Infusion on Surgical Recovery
Vanderbilt University Medical Center
A Study of Oral Ibogaine in Opioid Withdrawal
atai Therapeutics, Inc.
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.